Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer

The insulin-like growth factor-1 receptor (IGF1R) emerged in recent years as a promising therapeutic target in oncology. Identification of potential biomarkers capable of predicting response to IGF1R-targeted therapy is of cardinal importance. Tumor suppressor BRCA1 has important roles in multiple p...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen-Sinai, Tali, Cohen, Zoya, Werner, Haim, Berger, Raanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489552/
https://www.ncbi.nlm.nih.gov/pubmed/28706506
http://dx.doi.org/10.3389/fendo.2017.00148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489552/
https://www.ncbi.nlm.nih.gov/pubmed/28706506
http://dx.doi.org/10.3389/fendo.2017.00148

Ejemplares similares